Phase 4 PAP Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)
Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)Human Papillomavirus (HPV) InfectionsHigh-risk HPV+1 more
Miquel Angel Pavon Ribas69 enrolled1 locationNCT05334706
Recruiting
Phase 4
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV
Human Papilloma VirusHPVHuman Immunodeficiency Virus
University of British Columbia275 enrolled10 locationsNCT05495906
Recruiting
Phase 4
Zopa Retreatment and Vector Shedding in Adults With RRP
Recurrent Respiratory PapillomatosisPapillomavirus InfectionPapillomaviridae
Precigen, Inc30 enrolled3 locationsNCT06538480
Recruiting
Phase 4
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
Human PapillomavirusHPV InfectionImmunization
The University of Texas Medical Branch, Galveston618 enrolled1 locationNCT05672927
Recruiting
Phase 4
Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
Papillomavirus InfectionHuman Immunodeficiency VirusCervical Intraepithelial Neoplasia+4 more
Louisiana State University Health Sciences Center in New Orleans250 enrolled1 locationNCT05266898
Recruiting
Phase 4
Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.
Human Papilloma Virus
Labo'Life284 enrolled12 locationsNCT04232917